Medical Device | May 20, 2026
Shaily gets regulatory nod for launch of ShailyPen Neo device technology
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The development comes as stroke remains one of the world’s biggest health threats
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
Subscribe To Our Newsletter & Stay Updated
